Yat Sun Or Enanta Pharmaceuticals Inc (ENTA) insider trading activity

Yat Sun Or is Chief Scientific Officer of ENANTA PHARMACEUTICALS INC. Currently has a direct ownership of 374,535 shares of ENTA, which is worth approximately $2.91 Million. The most recent transaction as insider was on Feb 12, 2025, when has been sold 4,324 shares (Common Stock) at a price of $5.59 per share, resulting in proceeds of $24,171. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 375K

0.76% 3M change

0.33% 12M change

Total Value Held $2.91 Million

Yat Sun Or Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 12 2025	SELL Payment of exercise price or tax liability	$24,171 $5.59 p/Share	4,324 Reduced 1.14%	374,535 Common Stock
Feb 12 2025	BUY Grant, award, or other acquisition	-	9,750 Added 2.51%	378,859 Common Stock
Dec 06 2024	SELL Open market or private sale	$20,883 $8.06 p/Share	2,591 Reduced 0.7%	369,109 Common Stock
Dec 01 2024	SELL Payment of exercise price or tax liability	$13,717 $8.6 p/Share	1,595 Reduced 0.43%	371,700 Common Stock
Feb 12 2024	SELL Payment of exercise price or tax liability	$13,402 $12.41 p/Share	1,080 Reduced 0.29%	373,295 Common Stock
Feb 12 2024	BUY Grant, award, or other acquisition	-	3,680 Added 0.97%	374,375 Common Stock
Dec 05 2023	SELL Open market or private sale	$23,227 $9.63 p/Share	2,412 Reduced 0.65%	370,695 Common Stock
Dec 01 2023	SELL Payment of exercise price or tax liability	$15,136 $9.49 p/Share	1,595 Reduced 0.43%	373,107 Common Stock
Mar 15 2023	SELL Open market or private sale	$615,345 $44.19 p/Share	13,925 Reduced 3.58%	374,702 Common Stock
Mar 15 2023	BUY Exercise of conversion of derivative security	$194,950 $14.0 p/Share	13,925 Added 3.46%	388,627 Common Stock
Feb 13 2023	SELL Payment of exercise price or tax liability	$409,073 $52.77 p/Share	7,752 Reduced 2.03%	374,702 Common Stock
Feb 13 2023	BUY Grant, award, or other acquisition	-	23,267 Added 5.73%	382,454 Common Stock
Dec 01 2022	SELL Payment of exercise price or tax liability	$46,768 $44.33 p/Share	1,055 Reduced 0.29%	359,187 Common Stock
Nov 23 2022	BUY Grant, award, or other acquisition	-	21,000 Added 5.51%	360,242 Common Stock
Feb 14 2022	SELL Payment of exercise price or tax liability	$59,553 $62.49 p/Share	953 Reduced 0.28%	339,242 Common Stock
Feb 14 2022	BUY Grant, award, or other acquisition	-	3,034 Added 0.88%	340,195 Common Stock
Dec 01 2021	SELL Payment of exercise price or tax liability	$48,838 $87.68 p/Share	557 Reduced 0.16%	337,161 Common Stock
Nov 19 2021	BUY Grant, award, or other acquisition	-	6,800 Added 1.97%	337,718 Common Stock
Jan 26 2021	BUY Exercise of conversion of derivative security	$172,121 $12.57 p/Share	13,693 Added 3.97%	330,918 Common Stock
Dec 15 2020	SELL Payment of exercise price or tax liability	$65,481 $42.52 p/Share	1,540 Reduced 0.48%	317,225 Common Stock
Dec 15 2020	BUY Exercise of conversion of derivative security	-	5,250 Added 1.62%	318,765 Common Stock
Nov 20 2020	BUY Grant, award, or other acquisition	-	7,600 Added 2.37%	313,515 Common Stock

YSO

Yat Sun Or

Chief Scientific Officer

Watertown, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ENTA shares.

Notify only if

Value

Insider Trading

Get notified when an Enanta Pharmaceuticals Inc insider buys or sells ENTA shares.

Notify only if

Operation

Value

Type

News

Receive news related to ENANTA PHARMACEUTICALS INC

Track Activities on ENTA

Account